Step 2: check the duration How long was it out
Similar to selective GLP-1RAs, slowing of gastric emptying is greatest with the initial dose of tirzepatide, with this effect diminishing over time [15]
Yes, if your skin can tolerate it
For a drug to passively diffuse through this layer, it typically needs to be: Small in molecular size Lipophilic (fat-soluble) However, GLP-1 molecules: Are too large and hydrophilic Cannot naturally penetrate the skin barrier Even if GLP-1 patches claim to have GLP-1 drugs, the molecules cannot pass through the skin barrier without support
For example, in oral dosing trials for diabetic neuropathy, patients receiving 1200 mg to 1800 mg per day of ALA had a greater occurrence of nausea, vomiting, and vertigo compared to those receiving 600 mg per day